We therefore examined the prevalence of elevated serum levels of IgA, Gd-IgA1 and glycan-specific IgG and IgA in IgAN patients and a large cohort of CKD controls to assess the utility of these biomarkers for the non-invasive diagnosis of IgAN. Here, IGHA1 is linked to chronic kidney disease.